CN107242550A - A kind of male sterility tailored version clinical nutrition formula and preparation method thereof - Google Patents
A kind of male sterility tailored version clinical nutrition formula and preparation method thereof Download PDFInfo
- Publication number
- CN107242550A CN107242550A CN201710516558.9A CN201710516558A CN107242550A CN 107242550 A CN107242550 A CN 107242550A CN 201710516558 A CN201710516558 A CN 201710516558A CN 107242550 A CN107242550 A CN 107242550A
- Authority
- CN
- China
- Prior art keywords
- parts
- male sterility
- powder
- vitamin
- clinical nutrition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 48
- 230000035764 nutrition Effects 0.000 title claims abstract description 44
- 206010021929 Infertility male Diseases 0.000 title claims abstract description 43
- 208000007466 Male Infertility Diseases 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims description 12
- 238000009472 formulation Methods 0.000 title abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 102
- 239000011782 vitamin Substances 0.000 claims abstract description 43
- 239000000203 mixture Substances 0.000 claims abstract description 42
- 229940088594 vitamin Drugs 0.000 claims abstract description 35
- 229930003231 vitamin Natural products 0.000 claims abstract description 35
- 235000013343 vitamin Nutrition 0.000 claims abstract description 35
- 235000008216 herbs Nutrition 0.000 claims abstract description 28
- 230000035622 drinking Effects 0.000 claims abstract description 27
- 230000010354 integration Effects 0.000 claims abstract description 27
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 20
- 235000013305 food Nutrition 0.000 claims abstract description 19
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 18
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- 241000196324 Embryophyta Species 0.000 claims abstract description 17
- 239000011573 trace mineral Substances 0.000 claims abstract description 15
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 15
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 14
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 14
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 14
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 14
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 14
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 14
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract description 14
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 241000237502 Ostreidae Species 0.000 claims abstract description 13
- 235000012054 meals Nutrition 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 13
- 235000020636 oyster Nutrition 0.000 claims abstract description 13
- 244000197580 Poria cocos Species 0.000 claims abstract description 12
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 12
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 8
- 239000003094 microcapsule Substances 0.000 claims abstract description 7
- 244000235659 Rubus idaeus Species 0.000 claims abstract description 5
- 235000013350 formula milk Nutrition 0.000 claims description 31
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 14
- 239000011701 zinc Substances 0.000 claims description 14
- 229910052725 zinc Inorganic materials 0.000 claims description 14
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 11
- 241000219780 Pueraria Species 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 9
- -1 phytosterol Chemical compound 0.000 claims description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 8
- 235000010755 mineral Nutrition 0.000 claims description 8
- 239000011707 mineral Substances 0.000 claims description 8
- 229920001503 Glucan Polymers 0.000 claims description 7
- 240000002547 Rosa roxburghii Species 0.000 claims description 7
- 235000000640 Rosa roxburghii Nutrition 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 4
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 241000208688 Eucommia Species 0.000 claims description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 2
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 235000010081 allicin Nutrition 0.000 claims description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 2
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 2
- 235000020243 first infant milk formula Nutrition 0.000 claims description 2
- 229930003944 flavone Natural products 0.000 claims description 2
- 150000002213 flavones Chemical class 0.000 claims description 2
- 235000011949 flavones Nutrition 0.000 claims description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 2
- 229960002442 glucosamine Drugs 0.000 claims description 2
- 235000012680 lutein Nutrition 0.000 claims description 2
- 229960005375 lutein Drugs 0.000 claims description 2
- 239000001656 lutein Substances 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 2
- 235000012661 lycopene Nutrition 0.000 claims description 2
- 229960004999 lycopene Drugs 0.000 claims description 2
- 239000001751 lycopene Substances 0.000 claims description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 2
- 235000021283 resveratrol Nutrition 0.000 claims description 2
- 229940016667 resveratrol Drugs 0.000 claims description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 2
- 210000003734 kidney Anatomy 0.000 abstract description 22
- 235000015097 nutrients Nutrition 0.000 abstract description 20
- 230000019100 sperm motility Effects 0.000 abstract description 12
- 210000004185 liver Anatomy 0.000 abstract description 8
- 210000000952 spleen Anatomy 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 235000003715 nutritional status Nutrition 0.000 abstract description 3
- 230000002950 deficient Effects 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 18
- 241000700159 Rattus Species 0.000 description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- 235000019197 fats Nutrition 0.000 description 15
- 238000011282 treatment Methods 0.000 description 14
- 208000000509 infertility Diseases 0.000 description 13
- 230000036512 infertility Effects 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 13
- 239000000463 material Substances 0.000 description 12
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 10
- 229920002774 Maltodextrin Polymers 0.000 description 10
- 239000005913 Maltodextrin Substances 0.000 description 10
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 10
- 229940035034 maltodextrin Drugs 0.000 description 10
- 239000002994 raw material Substances 0.000 description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 10
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 9
- 240000007651 Rubus glaucus Species 0.000 description 9
- 239000005862 Whey Substances 0.000 description 9
- 102000007544 Whey Proteins Human genes 0.000 description 9
- 108010046377 Whey Proteins Proteins 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- 208000021267 infertility disease Diseases 0.000 description 9
- 239000008101 lactose Substances 0.000 description 9
- 235000019154 vitamin C Nutrition 0.000 description 9
- 239000011718 vitamin C Substances 0.000 description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 8
- 235000010469 Glycine max Nutrition 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 108010073771 Soybean Proteins Proteins 0.000 description 8
- 229930003268 Vitamin C Natural products 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 231100000535 infertility Toxicity 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 235000019710 soybean protein Nutrition 0.000 description 8
- 241000512259 Ascophyllum nodosum Species 0.000 description 7
- 241000408747 Lepomis gibbosus Species 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 7
- 239000004006 olive oil Substances 0.000 description 7
- 235000008390 olive oil Nutrition 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 235000020236 pumpkin seed Nutrition 0.000 description 7
- 210000000582 semen Anatomy 0.000 description 7
- 244000068988 Glycine max Species 0.000 description 6
- 235000004347 Perilla Nutrition 0.000 description 6
- 244000124853 Perilla frutescens Species 0.000 description 6
- 235000010489 acacia gum Nutrition 0.000 description 6
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 6
- 235000015278 beef Nutrition 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 239000003240 coconut oil Substances 0.000 description 6
- 235000019864 coconut oil Nutrition 0.000 description 6
- QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical compound CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000003549 soybean oil Substances 0.000 description 6
- 235000012424 soybean oil Nutrition 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 5
- 241000206575 Chondrus crispus Species 0.000 description 5
- 240000003183 Manihot esculenta Species 0.000 description 5
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 235000013734 beta-carotene Nutrition 0.000 description 5
- 239000011648 beta-carotene Substances 0.000 description 5
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 5
- 229960002747 betacarotene Drugs 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 235000021277 colostrum Nutrition 0.000 description 5
- 210000003022 colostrum Anatomy 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 229960000304 folic acid Drugs 0.000 description 5
- 235000019152 folic acid Nutrition 0.000 description 5
- 239000011724 folic acid Substances 0.000 description 5
- 239000003292 glue Substances 0.000 description 5
- 239000004519 grease Substances 0.000 description 5
- 229960003512 nicotinic acid Drugs 0.000 description 5
- 235000001968 nicotinic acid Nutrition 0.000 description 5
- 239000011664 nicotinic acid Substances 0.000 description 5
- 229940055726 pantothenic acid Drugs 0.000 description 5
- 235000019161 pantothenic acid Nutrition 0.000 description 5
- 239000011713 pantothenic acid Substances 0.000 description 5
- 229960003080 taurine Drugs 0.000 description 5
- 210000001550 testis Anatomy 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 239000011716 vitamin B2 Substances 0.000 description 5
- 239000011726 vitamin B6 Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- 235000008939 whole milk Nutrition 0.000 description 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 229920001202 Inulin Polymers 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 229930003270 Vitamin B Natural products 0.000 description 4
- 229930003316 Vitamin D Natural products 0.000 description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229960005069 calcium Drugs 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000011162 core material Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000035558 fertility Effects 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 4
- 229940029339 inulin Drugs 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 229940091250 magnesium supplement Drugs 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000001850 reproductive effect Effects 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 235000019156 vitamin B Nutrition 0.000 description 4
- 239000011720 vitamin B Substances 0.000 description 4
- 235000019166 vitamin D Nutrition 0.000 description 4
- 239000011710 vitamin D Substances 0.000 description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 description 4
- 229940046008 vitamin d Drugs 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 235000000421 Lepidium meyenii Nutrition 0.000 description 3
- 240000000759 Lepidium meyenii Species 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- QHOPXUFELLHKAS-UHFFFAOYSA-N Thespesin Natural products CC(C)c1c(O)c(O)c2C(O)Oc3c(c(C)cc1c23)-c1c2OC(O)c3c(O)c(O)c(C(C)C)c(cc1C)c23 QHOPXUFELLHKAS-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000006286 aqueous extract Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 229930000755 gossypol Natural products 0.000 description 3
- 229950005277 gossypol Drugs 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 235000012902 lepidium meyenii Nutrition 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 230000002381 testicular Effects 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 description 2
- 229920002752 Konjac Polymers 0.000 description 2
- 108010059881 Lactase Proteins 0.000 description 2
- 102100024028 Progonadoliberin-1 Human genes 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 101000996723 Sus scrofa Gonadotropin-releasing hormone receptor Proteins 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 210000000918 epididymis Anatomy 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000003132 food thickener Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 229940116108 lactase Drugs 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 210000001741 seminiferous epithelium Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000021595 spermatogenesis Effects 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011670 zinc gluconate Substances 0.000 description 2
- 235000011478 zinc gluconate Nutrition 0.000 description 2
- 229960000306 zinc gluconate Drugs 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- YVWMHFYOIJMUMN-CYZWUHAYSA-N (6e,8e)-5-oxooctadeca-6,8-dienoic acid Chemical compound CCCCCCCCC\C=C\C=C\C(=O)CCCC(O)=O YVWMHFYOIJMUMN-CYZWUHAYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241001300674 Plukenetia volubilis Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 241000287420 Pyrus x nivalis Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000123889 Rubus chingii Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000030120 acrosome reaction Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- LKDRXBCSQODPBY-ZXXMMSQZSA-N alpha-D-fructopyranose Chemical compound OC[C@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-ZXXMMSQZSA-N 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000026109 gonad development Effects 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 210000003552 inferior colliculi Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000005659 seminal clot liquefaction Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000008010 sperm capacitation Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000007863 steatosis Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Pediatric Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of male sterility tailored version clinical nutrition formula, it includes 15 40 parts of protein, 28 parts of fat, 40 55 parts of carbohydrate, 5.8 8 parts of dietary fibers, 0.6 1.2 parts of macroelements, 0.01 0.04 parts of trace elements, 0.005 0.02 parts of liposoluble vitamins, 0.008 0.2 parts of water soluble vitamins, 0.05 1 parts of meals elite, 0.1 2 parts of integration of drinking and medicinal herbs compositions, 0.1 3 parts of natural plants compounds and 0.005 5 parts of new resource foods, wherein integration of drinking and medicinal herbs composition is selected from Poria cocos, raspberry, matrimony vine, Chinese yam, spina date seed, oyster, at least one of radix glycyrrhizae;Above-mentioned each component is previously prepared into powder, wherein fat and vitamin are prepared into powder using micro-capsule embedding techniques.Screening and proportioning by said components, nutrient formulation of the present invention provides more reasonable, comprehensive nutritional support for male sterility patient, to improve nutritional status defective mode potential and having occurred, kidney tonifying, invigorating the spleen, soothing the liver composition are added simultaneously, to improve the condition of male sterility person, promote production of sperm ability, improve sperm motility.
Description
Technical field
The present invention relates to special medicine purposes formula food field, and in particular to a kind of male sterility tailored version clinical nutrition
Formula and preparation method thereof.
Background technology
The World Health Organization (WHO) provides that Mr. and Mrs live together more than 1 year after marriage, there is the sexual life of normal rule, does not use and appoints
What contraceptives, the wife's side is normal, and the infertile person in the wife's side, referred to as male sterility are caused due to male's aspect.In recent years, it is male
The property sterility incidence of disease is gradually risen, and the 15%-20% couple at child-bearing age is there are about according to relevant report, in world wide to be given birth to,
The factor on the wherein bridegroom's or husband's side accounts for 50%.The cause of disease of sterility is sufficiently complex, and because man's reproduction link is a lot, main has man
The Neuroendocrine regulation of reproductive system, the spermatogenesis of testis, sperm is ripe in epididymis, with essence in sperm discharge process
Capsule, the refining of prostatic secretions mix seminal fluid, and sperm is excreted and is input in female genital tract from man's genital tract,
Sperm in women fallopian tubal with the link such as ovum fertilization, any one factor or link are interfered and can drawn during these
Infertility is played, therefore, up to 60%-75% patient can not find out the specific cause of disease.
For traditional Chinese medical science angle, the kidney being the origin of congenital constitution, and main bone gives birth to marrow, it is main grow, reproduction, main menses and reproduction it
Essence.Kidney is because of deficiency, deficiency of kidney-essence, so as to cause semen quality to change, and it is thin lack of quantity of spermatic fluid, seminal fluid quality occur, sperm
Lazy weight.The deficiency of Yin not intrinsic energy sun, mutually fire is partially prosperous, and essence closes not solid, can cause to pass out semen, heat of urinating.Deficiency of kidney-QI, qi-blood deficiency can go out
The lesions such as existing impotence, seminal emission, sperm motility decline, the reduction of sperm quantity and morphological change, so as to cause male sterility
Generation.Therefore the traditional Chinese medical science uses nourishing kidney yin, the method for life essence-filling, marrow-benefitting is to mend its this void, kidney tonifying, essence replenishing, so as to treat male sterility
Disease.In addition, the method such as treatment by Chinese herbs, acupuncture, massage also is available for selection.
For doctor trained in Western medicine angle, after the diagnosis of clear and definite male sterility, the assessment of detailed fertility need to be done to the wife's side, then select
Select medical treatment or surgical intervention.Medical treatment mainly has prophylactic treatment and drug therapy.Wherein, the cause of disease is examined in drug therapy
It is disconnected clear and definite, there is etiotropic therapeutic measures person, therapeutic effect is then more satisfied with, such as gonadotropin hormone treatment;Pulsed
GnRH is treated;Promote endogenous gonadotrophin secretion;Other treating endocrine diseases etc..When the cause of disease is clear and definite but this cause of disease is drawn
When the mechanism for playing infertility is not yet illustrated, therapeutic effect is often not enough satisfied with.It is organic for some in male sterility patient
Lesion, it is impossible to solved by medicine, can take operative treatment.
Auxiliary procreation technology (assisted reproductive technology, ART), refers to and is arranged with various medical treatment
Apply, infertile Mr. and Mrs is become pregnant the general designation of method, including artificial insemination, vitro fertilization-embryo implanting.Its process is using non-
The mode that sexual intercourse means are become pregnant is, it is necessary to which the related personnel such as clinician and laboratory technicians joint operation treatment men and women is infertile
The important means of infertility.Human sperm bank and the part that sperm super-low temperature preservation is also auxiliary procreation technology.
With molecular biology, physiology, clinical medical development, modern nutritional support starts to play " pharmacology nutrition "
Effect.For can cause male sterility such as dysspermatism, dyszoospermia, sperm and ovum combination obstacle and it is systemic because
Plain the problems such as, modern clinic nutrition can improve, nurse one's health physical function, and appropriate nutrients is provided by suitable approach
Matter, corrects abnormal pathologic, the physiological change of patient, maintains body cell and tissue, the normal configuration and function of organ, improves body
Voxel matter, improves therapeutic effect.
Pass through clinical nutrition auxiliary treatment male sterility, it is possible to the drug treatment of abundant male sterility, or can
Some beneficial complements are provided for the treatment of sterility, so as to improve clinical efficacy.
At present, for the treatment of male sterility, the medicine and operative treatment of doctor trained in Western medicine, and the traditional Chinese medical science are included to the tune of internal organs
Physiotherapy method, acupuncture and massage, they all lack the supply to the overall nutrition of human body, it is impossible to meet need of the body to various nutrients
Ask.Therefore, develop can provide basal nutrient needed for male sterility patient it is plain while, special dietary can be supplemented again and is usually carried
The product of high therapeutic effect, with important value and wide market.
The content of the invention
It is an object of the invention to overcome defect of the prior art to match somebody with somebody there is provided a kind of male sterility tailored version clinical nutrition
Side and preparation method thereof.
Nutrient refers to the chemical composition for providing energy, participation body composition and regulation of physiological functions in food to human body.
Nutrition necessary to human body have protein, lipid, carbohydrate, mineral matter, vitamin, water, dietary fiber etc..Some research hairs
Existing, many nutrients are relevant with Hypothalamus-pituitary-testicular germ s function and spermatogenesis, maturation, capacitation, acrosome reaction etc..
The purpose of the present invention provides the nutritional support of comprehensive abundance for male sterility person, to improve nutritional status potential and having occurred not
Good state, while adding kidney tonifying, invigorating the spleen, soothing the liver integration of drinking and medicinal herbs composition, to improve the condition of male sterility person, promotes life
Smart ability, improves sperm motility.
To achieve the above object, the present invention is adopted the following technical scheme that:
On the one hand, the present invention provides a kind of male sterility tailored version clinical nutrition formula, including following component and its weight
Number:15-40 parts of protein, 2-8 parts of fat, 40-55 parts of carbohydrate, 5.8-8 parts of dietary fibers, 0.6-1.2 parts of constants
Element, 0.01-0.04 parts of trace elements, 0.005-0.02 parts of liposoluble vitamins, 0.008-0.2 parts of water soluble vitamins,
0.05-1 parts of meals elite, 0.1-2 parts of integration of drinking and medicinal herbs compositions, 0.1-3 parts of natural plants compounds and 0.005-5 parts of new resources
Food.
In order to further optimize above-mentioned technical proposal, the technical measures that the present invention is taken also include:
Preferably, the protein be selected from PURE WHEY, hydrolysis Isin glue collagen, soybean protein isolate, whole milk powder,
At least one of dried whole-egg, lactoferrin, colostrum, amino acid, protein peptides;
Wherein, the amino acid is selected from 1B-Pidolidone, Pidolidone, L-arginine, L-Trp, L- paddy
At least one of glutamine, taurine, Valine, ILE, L-Leu;The protein peptides are selected from soy oligosaccharides
At least one of peptide, wheat protein peptide, pupa albumen peptide, ocean fish oligopeptide powder, laughable peptide, amino peptide, ovalbumin peptide.
Preferably, the fat includes saturated fatty acid, polyunsaturated fatty acid, monounsaturated fatty acids, OPO structures
At least one of fat, DHA, EPA, ARA, phosphatide, more specifically it is described fat include safflower seed oil, walnut oil, peanut oil,
Soybean oil, Ah's glycerine, olive oil, tea oil, oil and fat of sacha inchi, olive oil, coconut oil, perilla herb oil, deep sea fish oil, cupu oil, palm
Oil, butter, cream, lard, medium chain triglyceride, lecithin etc..
Preferably, the carbohydrate is included in fructose, rock sugar, lactose, maltodextrin, tapioca, resistant starch
At least two.
Preferably, the dietary fiber comprising inulin, konjaku flour, galactooligosaccharide, FOS, oligoisomaltose,
At least one of soybean polyoses, cyclodextrin, resistant dextrin, soybean fiber.
Preferably, the macroelement is selected from calcium citrate, L-calcium lactate, calcium monohydrogen phosphate, K-IAO, sodium citrate
At least one of with magnesium gluconate.
Preferably, the trace element is selected from ferrous gluconate, KI, zinc gluconate, sodium selenite, glucose
At least one of sour copper, chromium sulfate, manganese gluconate and sodium molybdate.
Preferably, the liposoluble vitamin is selected from vitamin A, beta carotene, vitamin D3, vitamin E, vitamin
K1At least one of.
Preferably, the water soluble vitamin is selected from vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin
At least one of C, pantothenic acid, folic acid, nicotinic acid, choline, inositol, biotin.
Preferably, the meals elite is selected from cereal, beans, potato class, greengrocery, Homonemeae, nut-seed class, fishes and shrimps
At least one of class, poultry meat, fruits;The cereal is selected from rice meal, millet powder, black rice flour, coixlacrymajobi powder, corn
At least one of powder, wheat germ powder, oatmeal, buckwheat;The beans is selected from peameal, mung bean flour, black bean powder, red bean
At least one of powder, soy meal;The potato class is mainly made up of common yam rhizome powder;The Vegetable powder is selected from carrot meal, white radish powder, south
At least one of melon powder, spinach powder, tomato meal, broccoli powder, balsam pear powder;The Homonemeae be selected from mushroom powder, Kelp Powder and
At least one of white fungus powder;The nut-seed class is selected from least one of pumpkin seed powder and lotus nut starch;The fish and shrimp
Selected from least one of salmon powder and cod meal;The poultry meat in chicken meal, powdered beef and pig kidney powder extremely
Few one kind;The fruits are selected from least one of red date powder, longan powder, apple powder, cherry powder, citrus powder, pyrus nivalis powder;More
Preferably pumpkin seed powder, Kelp Powder, powdered beef and pig kidney powder.
Preferably, the integration of drinking and medicinal herbs composition is in Poria cocos, raspberry, matrimony vine, Chinese yam, spina date seed, oyster, radix glycyrrhizae
It is at least one;More preferably Poria cocos, raspberry, matrimony vine, Chinese yam, spina date seed, oyster.
Preferably, the natural plants compound is selected from l-cn, Glucosamine, FOS, lutein, plant
At least one of sterol, lycopene, resveratrol, allicin;More preferably l-cn.
Preferably, the new resource food is selected from first milk basic protein, γ-aminobutyric acid, chitosan oligosaccharide, eucommia Bark male flower, bamboo
In leaf flavones, CPP, avenabeta glucosan, yeast beta-dextran, newborn mineral salt, pueraria root powder, Rosa roxburghii, xylo-oligosaccharide
At least one;More preferably newborn mineral salt, pueraria root powder, Rosa roxburghii and avenabeta glucosan.
Preferably, the parts by weight of each component are as follows in the integration of drinking and medicinal herbs composition:0-1 parts of Poria cocos, 0-1 parts of raspberry,
0-1 parts of matrimony vine, 0-1 parts of Chinese yam, 0-1 parts of spina date seed, 0-1 parts of oyster.
Preferably, the good protein weight provided in the protein accounts for more than the 70% of gross protein weight.
Preferably, n-6 aliphatic acid in the male sterility tailored version clinical nutrition formula:N-3 aliphatic acid=3~4:1.
Preferably, ascorbic parts by weight are 0.102 part in the water soluble vitamin.
Preferably, the parts by weight of element zinc are 0.016 part in the trace element.
On the other hand, the present invention also provides a kind of preparation method side of above-mentioned male sterility tailored version clinical nutrition formula
Method, it comprises the following steps:
Step 1) fat powder, liposoluble vitamin powder and water soluble vitamin powder are prepared using micro-capsule embedding techniques
End;
Step 2) integration of drinking and medicinal herbs component powders are prepared using crushing, decoction, spray drying and sifting step;
Step 3) protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, meals are smart
China, natural plants compound and new resource food are prepared into the powder that particle diameter is 150~250 μm respectively;
Step 4) by step 1)-step 3) and obtained by powder sequentially add mixer it is well mixed after formula mixing is made
Thing, it is standby after sterilization processing;
Step 5) according to conventional technical means by step 4) in formula mixture be prepared into nutrient powder, nutrition emulsion, glue
At least one of wafer, tablet, pill or oral liquid.
Finally, the present invention relates to a kind of product prepared by above-mentioned male sterility tailored version clinical nutrition formula, including battalion
Support powder, nutrition emulsion, capsule, tablet, pill, oral liquid etc..
In above-mentioned preparation method, wherein, the raw material of the integration of drinking and medicinal herbs composition is crushed, water extraction concentration, and will be dense
Contracting liquid carries out spray drying and integration of drinking and medicinal herbs component powders is made;Wherein, the vitamin and fat respectively by microencapsulation at
Reason is prepared into vitamin powder and fat powder.
Preferably, the preparation process of the integration of drinking and medicinal herbs component powders is as follows:Using pulverizer to predetermined weight number
Raw material is crushed, and the raw material of crushing is placed in container, is added 3~8 times of the water that weight is raw material weight, is carried out immersion 3
~4 hours, then soak is carried out to decoct 30~60min, filtering removes raw material, leaves and takes decoction liquor, spray decoction liquor
Mist is dried, prepares integration of drinking and medicinal herbs component powders with 60~80 mesh sieves point.
Preferably, what the microencapsulation of the vitamin was handled comprises the following steps that:1) it regard liposoluble vitamin as core
Material, from sodium carboxymethylcellulose, gelatin, carragheen, xanthans, Arabic gum, maltodextrin, lipoprotein, corn syrup, big
Beans protein isolate, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, soybean fiber, lactose, rock sugar
One or more in powder, emulsifying agent, stabilizer are as wall material, high-pressure homogeneous emulsification, and spraying is instantaneous to be dried, with 60~80 mesh sieves
Divide and prepare liposoluble vitamin powder;2) using water soluble vitamin as core, from sodium carboxymethylcellulose, gelatin, OK a karaoke club
Glue, xanthans, Arabic gum, maltodextrin, lipoprotein, corn syrup, soybean protein isolate, whole-fat milk powder, dietary fiber, chrysanthemum
One or more works in powder, PURE WHEY, oligoisomaltose, soybean fiber, lactose, candy sugar powder, emulsifying agent, stabilizer
For wall material, it is well mixed, spraying is instantaneous to be dried, and water soluble vitamin powder is prepared with 60~80 mesh sieves point.
Preferably, the specific implementation step of the fatty micro-capsule embedding techniques is as follows:By fat, emulsifying agent, wall material with
Water mixed dissolution prepares emulsion;After the stirring mixing of above-mentioned emulsion, emulsifying homogeneous processing is carried out, spraying is then carried out dry
Dry, screening prepares fat powder, and fat powder is compared with conventional grease, and its dispersiveness, water solubility, emulsibility, inoxidizability are all
Improve a lot;Wherein, the emulsifying agent be selected from fatty acid glyceride (glyceride), methyl glycol fatty acid ester (propylene glycol ester),
One in sorbitan aliphatic ester (sorbitan acid), sucrose fatty ester (sucrose ester), lecithin, monoglyceride, Tween 80
Plant or a variety of;The wall material is selected from sodium carboxymethylcellulose, gelatin, carragheen, xanthans, Arabic gum, maltodextrin, fat egg
In vain, corn syrup, soybean protein isolate, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, soybean
One or more in fiber, lactose, candy sugar powder, emulsifying agent, stabilizer.
It is above-mentioned using Poria cocos, raspberry, matrimony vine, Chinese yam, spina date seed, the integration of drinking and medicinal herbs composition of oyster is included in the present invention
Composition has kidney tonifying, invigorating the spleen, soothing the liver effect.
Triterpenes, water-soluble polysaccharide and acidic polysaccharose play the role of to adjust immunologic function in Poria cocos, can make mice serum
Interior immune factor IL-2 and TNF-α content substantially increase, and wherein pachymaran can also such as increase IL- to affecting cells
2nd, TNF, IL-6, IFN-γ potency, the function of improving lymphocyte and macrophage, cause anti-Patrick's knot, lymphonodi mesenterici
In CD3+, CD19+ cell proportion change and promote mice serum in IgA, IgG and IgM biosynthesis.
Raspberry is the dry fruit of rosaceous plant rubus chingii Hu, with kidney-nourishing, controlling nocturnal emission with astringent drugs, contracting urine effect, for kidney
The treatment of the diseases such as the empty enuresis, frequent urination, impotence and premature ejaculation, emission and spermatorrhea.Raspberry aqueous extract can reduce experimental rat inferior colliculus
Brain LHRH, hypophysis LH, FSH and sexual gland E2 contents, and improve thymus gland LHRH and blood T levels.Research shows raspberry Aqueous extracts
It is probably the pharmacological basis of its " the puckery essence of kidney tonifying " to the regulating and controlling effect of gonad axis.
LBP-X has repair to hepatic injury caused by carbon tetrachloride in matrimony vine, and its mechanism may be by prevention
The damage of matter net, promotes protein synthesis and detoxication, recovers the function of liver cell, and promote liver cell regeneration;Matrimony vine is thick
Polysaccharide can reduce hepatic tissue mda content, and carbon tetrachloride hepatic injury mouse liver glycogen content can be made significantly to raise, and improve human body
Energy reserve;The active ingredient in matrimony vine can improve mitochondrial form to alcoholic liver disease of rats model, mitigate liver simultaneously
The steatosis and inflammation degree of necrosis of cell.
Spina date seed aqueous extract has obvious antiinflammatory action, can suppress mouse peritoneal, skin of back and auricle blood capillary
Pipe permeability, has inhibitory action to the granuloma that the swelling of rat hindleg egg white and the rat oxter implantation scraps of paper are produced, has
Effect of strengthen immunity.
The traditional Chinese medical science thinks, caused by infertility system " syndrome of deficiency of kidney yang ", " syndrome of deficiency of kidney yin ", " kidney essence deficiency ".Infertility side is thrown, point
Kidney-replenishing is not taken, mend lean blood, nourishing and suppressing Yang, the medicine of enriching essence and nourishing marrow, positive female engagement beneficial to spirit and marrow, so as to reach treatment kidney deficiency
The purpose of defective ejaculation, infertility.
Chinese yam especially Chinese yam polysaccharide has good immunoregulation effect, and Chinese yam can extend the low mouse of immunity function
The hypoxic tolerance time, improve spleen index, thymus index (P<0.05) thymus gland, the institutional framework of spleen, are improved.
Oyster nutrition liquid energy significantly reduces the blood urea nitrogen and blood lactase acid level of mouse, improves blood lactase acid resume speed, together
When can significantly extend the mice burden swimming time, oyster nutrient solution has antifatigue effect.
The present invention also adds the vitamin C of specified quantitative.Vitamin C energy high-efficient cleaning removes ascorbic concentration in ROS, refining
It is higher 10 times than in blood, the not oxidized destruction of sperm membrane lipid and sperm DNA can be protected to exempt to be damaged.Increase is ascorbic
Intake can increase the percentage of sperm motility rate and eupyrene sperm.In addition, vitamin C can reduce sperm cohesiveness in the cell,
Be conducive to semen liquefaction.Clinically it is proved effective in cure to nonliquefaction of semen person with replenishing vitamins C therapy.
The present invention also adds the trace element zinc of specified quantitative.Zinc can promote gonad development, participation immunity of organism, composition a variety of
Enzyme necessary to reproduction.Zinc in males is focused primarily upon in the organs such as testis, epididymis and prostate, can remove unnecessary ROS,
Increase LH, T secretion, promote testicualr development and Sperm specific enzyme, improve Sperm Motility, combined with Sperm Chromatin sulfydryl anti-
Only DNA fracture and depolymerization of being end-to-end etc..Infertile patients Seminal plasma zinc concentration is substantially less than fertile men, blood zinc concentration without
Notable difference, and Seminal plasma zinc concentration is proportionate with sperm concentration, sperm motility and sperm motility rate, but the zinc of excessive concentrations
Production of sperm can be suppressed.
Maca ene and the most valuable work(of macamide in the present invention also new resource food such as addition pueraria root powder, pueraria root powder
Effect is that human hormone can be kept to secrete dynamic equilibrium, and this has extraordinary effect to improving sexual function of human body obstacle;In maca
Arginine be sperm important composition composition, for increase sperm quantity have extraordinary effect, male can be effectively improved
Fecundity.Fructose is rich in maca, the vigor of mankind spermatozoon can be effectively improved, male fecundity is improved;Mustard in maca
Seed oil glycosides and its volatile oil component have the effect of extraordinary enhancing immune system, and this composition can effectively consolidate human body and exempt from
Epidemic disease system, improves sub-health state.
Compared with prior art, the invention has the advantages that:
(1) present invention addition has kidney tonifying, invigorating the spleen, the integration of drinking and medicinal herbs composition and new resource food of soothing the liver effect, its each group
Divide and complement each other, determined curative effect can improve the condition of male sterility person, promote production of sperm ability, improve sperm motility;
(2) present invention also adds the vitamin C and trace element zinc of specified quantitative, promotes testicualr development and Sperm specific enzyme, carries
The percentage of high Sperm Motility, increase sperm motility rate and eupyrene sperm;
(3) present invention prepares vitamin using micro-capsule embedding techniques, and vitamin is embedded in wall material, can prevent dimension from giving birth to
Element is destroyed by macroelement, trace element, extends the holding time of vitamin;The present invention is prepared using micro-capsule embedding techniques
Powdered oil so that powdered oil has preferable mobility, it is easy to be well mixed with other powdered components;And use micro-capsule bag
Bury after technology, grease is embedded in wall material, so that the contact with air is avoided to strengthen inoxidizability, so as to play guarantor
The maximum effect of strong type grease.
(4) raw material of male sterility tailored version clinical nutrition formula of the present invention is previously prepared in preparation process
Into 150~250 μm of powder, this make it that, when preparing finished product, each nutrition composition can be well mixed, it is ensured that in unit volume
The content of each nutrition composition is essentially identical, while when preparing liquid type preparation, each nutrition composition can be fully dispersed and completely molten
Solution prevents occurring solid precipitation in liquid into solvent, and effect of finished product product has been effectively ensured.
The present invention is by from rational basal nutrient element, using the proportioning of general equilibrium, while addition is with kidney tonifying, strong
The specific nutrients such as spleen, the integration of drinking and medicinal herbs composition of soothing the liver effect, natural plants compound, new resource food, and adjust its proportioning
Compatibility synergy is carried out with basal nutrient element, so that the nutrient formulation of allotment is easier to be absorbed by male sterility people digest,
Effect of its abundant component, improves the condition of male sterility person, promotes production of sperm ability, improves sperm motility.
Embodiment
The present invention provides a kind of clinical nutrition formula special for male sterility, including following component and its parts by weight
Number:15-40 parts of protein, 2-8 parts of fat, 40-55 parts of carbohydrate, 5.8-8 parts of dietary fibers, 0.6-1.2 parts of constant members
Element, 0.01-0.04 parts of trace elements, 0.005-0.02 parts of liposoluble vitamins, 0.008-0.2 parts of water soluble vitamins, 0.05-
1 part of meals elite, 0.1-2 parts of integration of drinking and medicinal herbs compositions, 0.1-3 parts of natural plants compounds and 0.005-5 parts of new resource foods.
With reference to embodiment, the embodiment to the present invention is further described.Following examples are only used for more
Plus technical scheme is clearly demonstrated, and can not be limited the scope of the invention with this.
Embodiment 1
The special clinical nutrition formula of male sterility of the present invention includes PURE WHEY 17g, soybean protein isolate
3.55g, whole milk powder 12.1g, dried whole-egg 0.33g, colostrum 0.17g, taurine 0.12g;Olive oil 0.92g, soybean oil
1.49g, coconut oil 0.92g, perilla herb oil 0.21g, medium chain triglyceride 0.07g;Maltodextrin 24.23g, tapioca 10g, ice
Sugared 6.23g, lactose 0.67g;Water-soluble dietary fiber 6g, insoluble diedairy fiber 1.16g in dietary fiber;Calcium in macroelement
0.53g, phosphorus 0.23g, potassium 0.05g, sodium 0.15g, magnesium 0.15g;Iron 0.011g, iodine 0.00014g, zinc in trace element
0.016g;Vitamin A 0.0005g, beta carotene 0.000057g, vitamin D in liposoluble vitamin30.000001g, dimension
Raw element E 0.008g;Vitamin B in water soluble vitamin10.001g, vitamin B20.001g, vitamin B60.0002g, dimension
Raw element B120.000001g, vitamin C 0.102g, pantothenic acid 0.003g, folic acid 0.000023g, nicotinic acid 0.0133g;Pumpkin seeds
Powder 0.07g, Kelp Powder 0.03g, powdered beef 0.17g, pig kidney powder 0.07g;Poria cocos 0.17g, raspberry in integration of drinking and medicinal herbs composition
0.17g, matrimony vine 0.17g, Chinese yam 0.17g, spina date seed 0.17g, oyster 0.17g;L-cn 2g in natural plants compound;Newly
Rosa roxburghii 0.33g, pueraria root powder 3.3g, newborn mineral salt 0.16g, avenabeta glucosan 0.03g in resource food.
Embodiment 2
The special clinical nutrition formula of male sterility of the present invention includes PURE WHEY 17g, soybean protein isolate
3.55g, whole milk powder 12.1g, dried whole-egg 0.33g, colostrum 0.17g, taurine 0.12g;Olive oil 0.92g, soybean oil
1.49g, coconut oil 0.92g, perilla herb oil 0.21g, medium chain triglyceride 0.07g;Maltodextrin 24.23g, tapioca 10g, ice
Sugared 6.23g, lactose 0.67g;Water-soluble dietary fiber 6g, insoluble diedairy fiber 1.16g in dietary fiber;Calcium in macroelement
0.53g, phosphorus 0.23g, potassium 0.05g, sodium 0.15g, magnesium 0.15g;Iron 0.011g, iodine 0.00014g, zinc in trace element
0.016g;Vitamin A 0.0005g, beta carotene 0.000057g, vitamin D in liposoluble vitamin30.000001g, dimension
Raw element E 0.008g;Vitamin B in water soluble vitamin10.001g, vitamin B20.001g, vitamin B60.001g, dimension
Raw element B120.000005g, vitamin C 0.102g, pantothenic acid 0.003g, folic acid 0.000223g, nicotinic acid 0.0133g;Pumpkin seeds
Powder 0.17g, Kelp Powder 0.33g, powdered beef 0.17g, pig kidney powder 0.07g;Poria cocos 0.17g, raspberry in integration of drinking and medicinal herbs composition
0.17g, matrimony vine 0.17g, Chinese yam 0.17g, spina date seed 0.17g, oyster 0.17g;L-cn 2g in natural plants compound;Newly
Rosa roxburghii 0.33g, pueraria root powder 3.3g, newborn mineral salt 0.16g, avenabeta glucosan 0.03g in resource food.
Embodiment 3
The special clinical nutrition formula of male sterility of the present invention includes PURE WHEY 17g, soybean protein isolate
3.55g, whole milk powder 12.1g, dried whole-egg 0.33g, colostrum 0.17g, taurine 0.12g;Olive oil 0.92g, soybean oil
1.49g, coconut oil 0.92g, perilla herb oil 0.21g, medium chain triglyceride 0.07g;Maltodextrin 24.23g, tapioca 10g, ice
Sugared 6.23g, lactose 0.67g;Water-soluble dietary fiber 6g, insoluble diedairy fiber 1.16g in dietary fiber;Calcium in macroelement
0.53g, phosphorus 0.23g, potassium 0.05g, sodium 0.15g, magnesium 0.15g;Iron 0.011g, iodine 0.00014g, zinc 0.016g in trace element;
Vitamin A 0.0005g, beta carotene 0.000057g, vitamin D in liposoluble vitamin30.000001g, vitamin E
0.008g;Vitamin B in water soluble vitamin10.001g, vitamin B20.001g, vitamin B60.001g, vitamin B12
0.000005g, vitamin C 0.102g, pantothenic acid 0.003g, folic acid 0.000223g, nicotinic acid 0.0133g;Pumpkin seed powder 0.17g,
Kelp Powder 0.33g, powdered beef 0.17g, pig kidney powder 0.07g;Poria cocos 0.07g, raspberry 0.07g, matrimony vine in integration of drinking and medicinal herbs composition
0.07g, Chinese yam 0.07g, spina date seed 0.07g, oyster 0.07g;L-cn 2g in natural plants compound;In new resource food
Rosa roxburghii 0.33g, pueraria root powder 3.3g, newborn mineral salt 0.16g, avenabeta glucosan 0.03g.
Embodiment 4
The special clinical nutrition formula of male sterility of the present invention includes PURE WHEY 10g, soybean protein isolate
10.55g, whole milk powder 12.1g, dried whole-egg 0.33g, colostrum 0.17g, taurine 0.12g;Olive oil 0.92g, soybean oil
1.49g, coconut oil 0.92g, perilla herb oil 0.21g, medium chain triglyceride 0.07g;Maltodextrin 24.23g, tapioca 10g, ice
Sugared 6.23g, lactose 0.67g;Water-soluble dietary fiber 6g, insoluble diedairy fiber 1.16g in dietary fiber;Calcium in macroelement
0.53g, phosphorus 0.23g, potassium 0.05g, sodium 0.15g, magnesium 0.15g;Iron 0.011g, iodine 0.00014g, zinc in trace element
0.016g;Vitamin A 0.0005g, beta carotene 0.000057g, vitamin D in liposoluble vitamin30.000001g, dimension
Raw element E 0.008g;Vitamin B in water soluble vitamin10.001g, vitamin B20.001g, vitamin B60.001g, dimension
Raw element B120.000005g, vitamin C 0.102g, pantothenic acid 0.003g, folic acid 0.000223g, nicotinic acid 0.0133g;Pumpkin seeds
Powder 0.17g, Kelp Powder 0.33g, powdered beef 0.17g, pig kidney powder 0.07g;Poria cocos 0.17g, raspberry in integration of drinking and medicinal herbs composition
0.17g, matrimony vine 0.17g, Chinese yam 0.17g, spina date seed 0.17g, oyster 0.17g;L-cn 2g in natural plants compound;Newly
Rosa roxburghii 0.03g, pueraria root powder 0.3g, newborn mineral salt 0.16g, avenabeta glucosan 0.03g in resource food.
Embodiment 5
A kind of preparation method of the special clinical nutrition formula of male sterility as described in embodiment 1- embodiments 4 is as follows:
1) powdered oil (powder fat) is prepared:
A) the wall material aqueous solution is prepared:Take 8 grams of maltodextrin, 4 grams of soybean protein isolate, 11 grams of whole-fat milk powder, dietary fiber 2
Gram (resistant dextrin), 0.5 gram of inulin, 5 grams of PURE WHEY, 0.5 gram of oligoisomaltose, 1 gram of soybean fiber, Arabic gum
0.2 gram, 0.5 gram of lactose, 2 grams of candy sugar powder, 50 milliliters of water stirs and (has ready conditions and heat while stirring to 60 DEG C, kept for 30 points
Room temperature is cooled to after clock).
B) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in (olive oil in 3.39 milliliters of greases monoglyceride
0.86 milliliter, 1.4 milliliters of soybean oil, 0.86 milliliter of coconut oil, 0.20 milliliter of perilla herb oil, 0.07 milliliter of medium chain triglyceride).
C) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in the wall material aqueous solution Tween 80.
D) the wall material aqueous solution of the mixed plant grease and addition Over emulsfication agent Tween 80 of Over emulsfication agent monoglyceride will be added
It is sufficiently mixed.
E) addition stabilizer agar takes 0.1 gram (total solid concentration is 0.2%) to enter after mixed solution, is settled to water
Disperse 2 minutes at a high speed under 200 milliliters (total solid concentration is 25%), 20000r/min.
F) homogenization pressure is 25MPa, and homogeneous emulsion is made in homogeneous 3 times (every time 5 minutes).
G) obtained emulsion is spray-dried, EAT is 195 DEG C, leaving air temp is 80 DEG C.Collect powder
Grease (powder fat).
2) integration of drinking and medicinal herbs component powders are prepared:The raw material of predetermined weight number is crushed using pulverizer, will be crushed
Raw material be placed in container, add weight be raw material weight 3~8 times of water, carry out immersion 3~4 hours, then to immersion
Liquid carries out decocting 30~60min, and filtering removes raw material, leaves and takes decoction liquor, decoction liquor is spray-dried, with 60~80 mesh sieves
Divide and prepare integration of drinking and medicinal herbs component powders;
3) vitamin powder is prepared:Using the liposoluble vitamin of predetermined weight number as core, from carragheen, I
Primary glue carries out 2 emulsifying homogeneous processing, the emulsifying homogeneous time is 10~15min, is then sprayed under high pressure as wall material
Mist is instantaneously dried, and liposoluble vitamin powder is prepared with 60~80 mesh sieves point;The water soluble vitamin of predetermined weight number is made
For core, from maltodextrin, lipoprotein as wall material, it is well mixed, spraying is instantaneous to be dried, and water is prepared with 60~80 mesh sieves point
Soluble vitamin powder;
4) by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, meals elite,
Natural plants compound and new resource food are prepared into the powder that particle diameter is 150~250 μm respectively;
5) by step 1)~step 4) obtained by powder sequentially add the mixers of cone-type mixer or other forms and mix
Uniformly obtained formula mixture is closed, it is standby after sterilization processing;
6) according to conventional technical means by step 5) in formula mixture be prepared into nutrient powder, nutrition emulsion, capsule,
At least one of tablet, pill or oral liquid.
In step 6) in, optionally increase appropriate food thickening agent and food additives.The food thickening agent
It is described at least one of guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum
Food additives are at least one of Aspartame, flavoring essence spices, brown sugar;More preferably carragheen, Arabic gum, Guar
Glue, Aspartame, flavoring essence spices.
Aforesaid operations step is both needed to carry out under the protection of inert gas, such as nitrogen, argon gas, helium etc., to prevent production
The danger of green powder blast.
According to described with the classifications such as powdery, graininess, capsule shape, tablet shape, beverage can be prepared into.
The infertility experiment of embodiment 6- male mices
1) influence of the tailored version clinical nutrition formula that the present invention is provided to male mouse infertility.
The nutrient powder for taking the embodiment of the present invention 1~4 to prepare is tested, while setting comparative example 1, comparative example 2, comparative example 1
Using nutrient powder prepared by zinc gluconate, pumpkin seed powder, Kelp Powder, pueraria root powder is deleted in the nutrient formulation of embodiment 2, contrast
Example 2 is using nutrient powder prepared by integration of drinking and medicinal herbs composition is deleted in the nutrient formulation of embodiment 2, blank control group feeding is normal to raise
Material.
Wistar male rats 96 are taken, the modeling of sterility is carried out to male rat with gossypol.Experimental animal is divided at random
Into totally 8 groups of Normal group, model group, administration group 1, administration group 2, administration group 3, administration group 4, administration group 5, administration group 6, administration
Group 1,2,3,4 distinguishes the nutrient formulation that stomach raises embodiment 1,2,3,4, and the difference stomach of administration group 5,6 raises comparative example 1, comparative example 2.
The tailored version clinical nutrition of table 1 is formulated the influence to male rat body weight
Group | First body weight/g | Whole body weight/g | Weightening/g |
Administration group 1 | 26.3 | 44.2 | 17.9 |
Administration group 2 | 28.1 | 46.8 | 18.7 |
Administration group 3 | 27.8 | 45.9 | 18.1 |
Administration group 4 | 26.3 | 44.6 | 18.3 |
Administration group 5 | 25.8 | 42.3 | 16.5 |
Administration group 6 | 26.9 | 42.6 | 15.7 |
Control group | 27.4 | 41.6 | 14.2 |
Model group | 27.3 | 43.2 | 15.9 |
Table 1 understands that administration group 1,2,3,4,5,6 is compared with control group, P < 0.05, illustrates clinical nutrition formula to rat
Weightening has obvious effect;And administration group rat is able to maintain that normal physiological function, the normal growth of rat is not produced not
Good influence.
2) the tailored version clinical nutrition that the present invention is provided is formulated the influence to male rat reproductive function.
Wistar male rats 96 are taken, the modeling of sterility is carried out to male rat with gossypol.Experimental animal is divided at random
Into totally 8 groups of Normal group, model group, administration group 1, administration group 2, administration group 3, administration group 4, administration group 5, administration group 6, administration
Group 1,2,3,4 distinguishes the nutrient formulation that stomach raises embodiment 1,2,3,4, and the difference stomach of administration group 5,6 raises comparative example 1, comparative example 2.Often
Each 12 of animal of group, counts 3 months.Male female mice was administered after 5 weeks by 1:2 ratio carries out the 1st wheel and mated, and separately equal proportion is changed after 1 week
Female mice carry out the 2nd wheel mate.Female mice after mating is dissected after 1 week, observes its become pregnant number and tire mouse number, male mouse is judged with this
Fertility.The dead male mouse in experiment periods end, determines testicular weight, takes histotomy to make histopathological examination, observe sperm shape
State, energy, calculate sperm number, activity ratio, take average for comparing.
The tailored version clinical nutrition of table 2 is formulated the influence to male rat reproductive function
Group | Testis weight in wet base (mg)/body weight (g) |
Administration group 1 | 6.43±0.64 |
Administration group 2 | 6.73±0.53 |
Administration group 3 | 6.33±0.59 |
Administration group 4 | 6.39±0.66 |
Administration group 5 | 5.57±0.62 |
Administration group 6 | 5.32±0.39 |
Control group | 6.12±0.46 |
Model group | 3.45±0.55 |
Table 2 understands that administration group 1,2,3,4,5,6 is compared with model group, P < 0.05, illustrates administration group rat testicle weight in wet base
(P < 0.05) is increased significantly compared with gossypol model group animal with body weight ratio, and the developmental condition of Testicular Seminiferous Epithelium substantially enters
Step.Administration group 1,2,3,4 is compared with administration group 5,6, P < 0.05, illustrates the rat testicle weight in wet base of administration group 1,2,3,4 and weight ratio
Value is increased significantly (P < 0.05) compared with administration group 5,6 animals, and the developmental condition of Testicular Seminiferous Epithelium substantially improves, research knot
Fruit shows that tailored version clinical nutrition formula has obvious facilitation to male rat reproductive function.
From above-described embodiment, various components mutually match in the special clinical nutrition formula of male sterility of the present invention
Close, reasonable, comprehensive nutritional support is provided for male sterility patient, to improve the bad shape of nutritional status potential and having occurred
State, while kidney tonifying, invigorating the spleen, soothing the liver integration of drinking and medicinal herbs composition, natural plants compound and new resource food are added, to improve male
The condition of sterile person, promotes production of sperm ability, improves sperm motility.
The specific embodiment of the present invention is described in detail above, but it is only used as example, and the present invention is not intended to limit
In particular embodiments described above.To those skilled in the art, it is any to the equivalent modifications that carry out of the present invention and to replace
In generation, is also all among scope of the invention.Therefore, the equalization made without departing from the spirit and scope of the invention is converted and repaiied
Change, all should be contained within the scope of the invention.
Claims (9)
1. a kind of male sterility tailored version clinical nutrition formula, it is characterised in that including following component and its parts by weight:15-
40 parts of protein, 2-8 parts of fat, 40-55 parts of carbohydrate, 5.8-8 parts of dietary fibers, 0.6-1.2 parts of macroelements,
0.01-0.04 parts of trace elements, 0.005-0.02 parts of liposoluble vitamins, 0.008-0.2 parts of water soluble vitamins, 0.05-1 parts
Meals elite, 0.1-2 parts of integration of drinking and medicinal herbs compositions, 0.1-3 parts of natural plants compounds and 0.005-5 parts of new resource foods;
Wherein, the integration of drinking and medicinal herbs composition in Poria cocos, raspberry, matrimony vine, Chinese yam, spina date seed, oyster, radix glycyrrhizae at least one
Kind;
Wherein, the new resource food be selected from first milk basic protein, γ-aminobutyric acid, chitosan oligosaccharide, eucommia Bark male flower, bamboo-leaves flavones,
In CPP, avenabeta glucosan, yeast beta-dextran, newborn mineral salt, pueraria root powder, Rosa roxburghii, xylo-oligosaccharide at least
It is a kind of.
2. a kind of male sterility tailored version clinical nutrition formula according to claim 1, it is characterised in that the natural plant
Compounds are selected from l-cn, Glucosamine, FOS, lutein, phytosterol, lycopene, resveratrol, big
At least one of allicin.
3. a kind of male sterility tailored version clinical nutrition formula according to claim 1, it is characterised in that the medicine food is same
The parts by weight of each component are as follows in derived components:0-1 parts of Poria cocos, 0-1 parts of raspberry, 0-1 parts of matrimony vine, 0-1 parts of Chinese yam, spina date seed
0-1 parts, 0-1 parts of oyster.
4. a kind of male sterility tailored version clinical nutrition formula according to claim 1, it is characterised in that the protein
The good protein weight of middle offer accounts for more than the 70% of gross protein weight.
5. a kind of male sterility tailored version clinical nutrition formula according to claim 1, it is characterised in that the male is not
Educate n-6 aliphatic acid in tailored version clinical nutrition formula:N-3 aliphatic acid=3~4:1.
6. a kind of male sterility tailored version clinical nutrition formula according to claim 1, it is characterised in that the water solubility
Ascorbic parts by weight are 0.102 part in vitamin.
7. a kind of male sterility tailored version clinical nutrition formula according to claim 1, it is characterised in that the micro member
The parts by weight of element zinc are 0.016 part in element.
8. a kind of preparation method of male sterility tailored version clinical nutrition formula as claimed in claim 1, it is characterised in that institute
State fat, liposoluble vitamin, water soluble vitamin be respectively adopted micro-capsule embedding techniques be made it is powdered, the integration of drinking and medicinal herbs into
Point by crush, decoct, be spray-dried and sieve be made it is powdered.
9. preparation method according to claim 8, it is characterised in that the fat, liposoluble vitamin, water soluble vitamin life
The mesh number that element and integration of drinking and medicinal herbs composition sieve is 60-80 mesh.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710516558.9A CN107242550A (en) | 2017-06-29 | 2017-06-29 | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710516558.9A CN107242550A (en) | 2017-06-29 | 2017-06-29 | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107242550A true CN107242550A (en) | 2017-10-13 |
Family
ID=60014243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710516558.9A Pending CN107242550A (en) | 2017-06-29 | 2017-06-29 | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107242550A (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107594540A (en) * | 2017-11-05 | 2018-01-19 | 耿德铨 | Help and breed nutriment composite powder and preparation method thereof |
CN107897768A (en) * | 2017-11-30 | 2018-04-13 | 重庆科斯蔓商贸有限公司 | It is a kind of to improve sperm quality and the protein composition and preparation method of sperm motility |
CN107927754A (en) * | 2017-12-13 | 2018-04-20 | 上海奥医生物医药科技有限公司 | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production |
CN107996718A (en) * | 2017-12-12 | 2018-05-08 | 安徽赛博蓝医疗科技有限公司 | A kind of composition health food with prenatal and postnatal care and its production technology |
CN108013452A (en) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof |
CN108041588A (en) * | 2017-12-08 | 2018-05-18 | 冯纪敏 | A kind of composition containing trehalose and its application |
CN108077911A (en) * | 2017-12-13 | 2018-05-29 | 上海奥医生物医药科技有限公司 | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof |
CN108095075A (en) * | 2017-12-13 | 2018-06-01 | 上海奥医生物医药科技有限公司 | Miscarriage women tailored version clinical nutrition formula and preparation method thereof |
CN108159265A (en) * | 2018-03-16 | 2018-06-15 | 上海锐因生物科技有限公司 | It is a kind of to be used to improve composition of male sterility and its preparation method and application |
CN108685865A (en) * | 2018-07-27 | 2018-10-23 | 东莞广易中医学研究中心(有限合伙) | Improve the integration of drinking and medicinal herbs chewing tabletting and preparation method thereof of male's immune function |
CN108703364A (en) * | 2018-05-10 | 2018-10-26 | 上海奥医生物医药科技有限公司 | Treating fatty acid metabolism tailored version clinical nutrition formula and preparation method thereof |
CN108703365A (en) * | 2018-05-10 | 2018-10-26 | 上海奥医生物医药科技有限公司 | Protein allergy tailored version clinical nutrition formula and preparation method thereof |
CN109007857A (en) * | 2018-08-29 | 2018-12-18 | 苏州佩普肽康生物科技有限公司 | Improve the food formula of special diet and preparation method thereof of mankind spermatozoon quality |
CN109172804A (en) * | 2018-11-22 | 2019-01-11 | 量子高科(中国)生物股份有限公司 | It is a kind of to improve spermatozoon activity, improving infertile composition and preparation method thereof |
CN109497563A (en) * | 2018-10-23 | 2019-03-22 | 上海奥医生物医药科技有限公司 | Leucoderma tailored version clinical nutrition formula and preparation method thereof |
CN110507808A (en) * | 2019-08-29 | 2019-11-29 | 山东福德特医生物工程有限公司 | A kind of composition and preparation method thereof improving mankind spermatozoon quality and weak defective ejaculation essence |
CN112244288A (en) * | 2020-10-22 | 2021-01-22 | 山东哈维药业有限公司 | Compound protein nutrient for male pregnancy preparation and preparation method thereof |
EP4256977A1 (en) * | 2022-04-06 | 2023-10-11 | The Ceutics Company GesmbH | Improving semen quality |
WO2023194470A1 (en) | 2022-04-06 | 2023-10-12 | The Ceutics Company Gesmbh | Improving semen quality |
WO2024170665A1 (en) * | 2023-02-17 | 2024-08-22 | Lo.Li. Pharma S.R.L. | Composition for the use in the treatment of polycystic ovary syndrome |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104083468A (en) * | 2014-05-31 | 2014-10-08 | 山东欣希安药业股份有限公司 | Medicine for treating male oligospermia and asthenozoospermia and improving sperm quality |
CN104187637A (en) * | 2014-08-15 | 2014-12-10 | 胡安然 | Full-nutritional formula food for tonifying Yang |
CN104839671A (en) * | 2015-04-13 | 2015-08-19 | 劲膳美生物科技股份有限公司 | Medicine formula food for tonifying Yang |
CN105559076A (en) * | 2016-02-29 | 2016-05-11 | 山东道之自然健康产业有限公司 | Get-pregnant male total-nutrient herbal cuisine paste |
CN105596885A (en) * | 2016-01-14 | 2016-05-25 | 梁晓会 | Medicine for treating male oligozoospermia and improving semen quality and preparation method of medicine |
CN106579460A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrition formula for fracture and preparation method thereof |
CN106666728A (en) * | 2016-12-23 | 2017-05-17 | 上海奥医生物医药科技有限公司 | Special clinical nutrient composition for gestational diabetes and preparation method of nutrient composition |
CN106858595A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | One kind burn tailored version clinical nutrition formula and preparation method thereof |
-
2017
- 2017-06-29 CN CN201710516558.9A patent/CN107242550A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104083468A (en) * | 2014-05-31 | 2014-10-08 | 山东欣希安药业股份有限公司 | Medicine for treating male oligospermia and asthenozoospermia and improving sperm quality |
CN104187637A (en) * | 2014-08-15 | 2014-12-10 | 胡安然 | Full-nutritional formula food for tonifying Yang |
CN104839671A (en) * | 2015-04-13 | 2015-08-19 | 劲膳美生物科技股份有限公司 | Medicine formula food for tonifying Yang |
CN105596885A (en) * | 2016-01-14 | 2016-05-25 | 梁晓会 | Medicine for treating male oligozoospermia and improving semen quality and preparation method of medicine |
CN105559076A (en) * | 2016-02-29 | 2016-05-11 | 山东道之自然健康产业有限公司 | Get-pregnant male total-nutrient herbal cuisine paste |
CN106579460A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrition formula for fracture and preparation method thereof |
CN106666728A (en) * | 2016-12-23 | 2017-05-17 | 上海奥医生物医药科技有限公司 | Special clinical nutrient composition for gestational diabetes and preparation method of nutrient composition |
CN106858595A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | One kind burn tailored version clinical nutrition formula and preparation method thereof |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107594540A (en) * | 2017-11-05 | 2018-01-19 | 耿德铨 | Help and breed nutriment composite powder and preparation method thereof |
CN107897768A (en) * | 2017-11-30 | 2018-04-13 | 重庆科斯蔓商贸有限公司 | It is a kind of to improve sperm quality and the protein composition and preparation method of sperm motility |
CN108041588A (en) * | 2017-12-08 | 2018-05-18 | 冯纪敏 | A kind of composition containing trehalose and its application |
CN107996718A (en) * | 2017-12-12 | 2018-05-08 | 安徽赛博蓝医疗科技有限公司 | A kind of composition health food with prenatal and postnatal care and its production technology |
CN107927754A (en) * | 2017-12-13 | 2018-04-20 | 上海奥医生物医药科技有限公司 | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production |
CN108013452A (en) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof |
CN108077911A (en) * | 2017-12-13 | 2018-05-29 | 上海奥医生物医药科技有限公司 | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof |
CN108095075A (en) * | 2017-12-13 | 2018-06-01 | 上海奥医生物医药科技有限公司 | Miscarriage women tailored version clinical nutrition formula and preparation method thereof |
CN108159265A (en) * | 2018-03-16 | 2018-06-15 | 上海锐因生物科技有限公司 | It is a kind of to be used to improve composition of male sterility and its preparation method and application |
CN108703364A (en) * | 2018-05-10 | 2018-10-26 | 上海奥医生物医药科技有限公司 | Treating fatty acid metabolism tailored version clinical nutrition formula and preparation method thereof |
CN108703365A (en) * | 2018-05-10 | 2018-10-26 | 上海奥医生物医药科技有限公司 | Protein allergy tailored version clinical nutrition formula and preparation method thereof |
CN108685865A (en) * | 2018-07-27 | 2018-10-23 | 东莞广易中医学研究中心(有限合伙) | Improve the integration of drinking and medicinal herbs chewing tabletting and preparation method thereof of male's immune function |
CN109007857A (en) * | 2018-08-29 | 2018-12-18 | 苏州佩普肽康生物科技有限公司 | Improve the food formula of special diet and preparation method thereof of mankind spermatozoon quality |
CN109497563A (en) * | 2018-10-23 | 2019-03-22 | 上海奥医生物医药科技有限公司 | Leucoderma tailored version clinical nutrition formula and preparation method thereof |
CN109172804A (en) * | 2018-11-22 | 2019-01-11 | 量子高科(中国)生物股份有限公司 | It is a kind of to improve spermatozoon activity, improving infertile composition and preparation method thereof |
CN110507808A (en) * | 2019-08-29 | 2019-11-29 | 山东福德特医生物工程有限公司 | A kind of composition and preparation method thereof improving mankind spermatozoon quality and weak defective ejaculation essence |
CN112244288A (en) * | 2020-10-22 | 2021-01-22 | 山东哈维药业有限公司 | Compound protein nutrient for male pregnancy preparation and preparation method thereof |
EP4256977A1 (en) * | 2022-04-06 | 2023-10-11 | The Ceutics Company GesmbH | Improving semen quality |
WO2023194470A1 (en) | 2022-04-06 | 2023-10-12 | The Ceutics Company Gesmbh | Improving semen quality |
WO2024170665A1 (en) * | 2023-02-17 | 2024-08-22 | Lo.Li. Pharma S.R.L. | Composition for the use in the treatment of polycystic ovary syndrome |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107242550A (en) | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof | |
CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN106962912A (en) | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof | |
CN103141709B (en) | Carp feed and preparation method thereof | |
CN106942748A (en) | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof | |
CN106858620A (en) | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof | |
CN106579393A (en) | Special clinical nutrient formula for diabetes and preparation method thereof | |
CN107319524A (en) | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof | |
CN107927754A (en) | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production | |
CN109123643A (en) | A kind of preparation method of cereal generation meal ball | |
CN106579460A (en) | Special clinical nutrition formula for fracture and preparation method thereof | |
KR101738912B1 (en) | Composition For Anti-obesity And Diet | |
CN108013454A (en) | Gynaecological imflammation tailored version clinical nutrition formula and preparation method thereof | |
CN106983151A (en) | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof | |
CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
CN107440120A (en) | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof | |
CN107373672A (en) | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof | |
CN107440103A (en) | A kind of respiratory disease tailored version clinical nutrition formula and preparation method thereof | |
CN107616490A (en) | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof | |
CN106578093A (en) | Wound, infection, operation and other stress state special-purpose clinical nutrition formula and preparation method thereof | |
CN110547470A (en) | A nutritional composition for improving male sexual function, and its preparation method | |
CN106858595A (en) | One kind burn tailored version clinical nutrition formula and preparation method thereof | |
CN107440102A (en) | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof | |
CN108013452A (en) | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171013 |